Ginkgo Bioworks Valuation Multiples

Ginkgo Bioworks Overview

About Ginkgo Bioworks

Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering: where company provide biological R&D services for customers across a range of industries and Biosecurity: where it provide services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.

Founded

2008

HQ

Employees

834

Website

ginkgobioworks.com

Sectors

BioindustrialsBioTechDeepTech

Financials (LTM)

Revenue: $168M

EBITDA: ($170M)

EV

$388M

Valuation Multiples

Multiples.vc

Start free trial

Ginkgo Bioworks Financials

Ginkgo Bioworks reported last 12-month revenue of $168M and negative EBITDA of ($170M).

In the same LTM period, Ginkgo Bioworks generated $123M in gross profit, ($170M) in EBITDA losses, and had net loss of ($308M).

Ginkgo Bioworks P&L

In the most recent fiscal year, Ginkgo Bioworks reported revenue of $170M and EBITDA of ($167M).

Ginkgo Bioworks expects next 12-month revenue of XXX and NTM EBITDA of XXX

Ginkgo Bioworks Stock Performance

Ginkgo Bioworks has current market cap of $427M, and enterprise value of $388M.

Ginkgo Bioworks' stock price is $7.05.

Ginkgo Bioworks Valuation Multiples

Ginkgo Bioworks trades at 2.3x EV/Revenue multiple, and (2.3x) EV/EBITDA.

Ginkgo Bioworks Financial Valuation Multiples

As of March 23, 2026, Ginkgo Bioworks has market cap of $427M and EV of $388M.

Equity research analysts estimate Ginkgo Bioworks' 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Ginkgo Bioworks has a P/E ratio of (1.4x).

Ginkgo Bioworks Margins & Growth Rates

Ginkgo Bioworks' revenue in the last 12 month declined by (5%).

Ginkgo Bioworks' revenue per employee in the last FY averaged $0.2M.

Ginkgo Bioworks' rule of 40 is (106%) (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Ginkgo Bioworks' rule of X is (114%) (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Ginkgo Bioworks Public Comps

See public comps and valuation multiples for other Bioindustrials comps.

Ginkgo Bioworks M&A Activity

Ginkgo Bioworks acquired XXX companies to date.

Last acquisition by Ginkgo Bioworks was on XXXXXXXX, XXXXX. Ginkgo Bioworks acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

Ginkgo Bioworks Investment Activity

Ginkgo Bioworks invested in XXX companies to date.

Ginkgo Bioworks made its latest investment on XXXXXXXX, XXXXX. Ginkgo Bioworks invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).